Article
SIRT1 regulates metabolism and leukemogenic potential in CML stem cells
9 Jun 2019
Abstract excerpt
Chronic myeloid leukemia (CML) results from hematopoietic stem cell transformation by the BCR-ABL kinase. Despite the success of BCR-ABL tyrosine kinase inhibitors (TKIs) in treating CML patients, leukemia stem cells (LSCs) resist elimination and persist as a major barrier to cure. Previous studies suggest that overexpression of the sirtuin 1 (SIRT1) deacetylase may contribute to LSC maintenance in CML. Here, by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
